Results 41 to 50 of about 447,619 (420)

Aspirin Resistance [PDF]

Advances in Hematology, 2009
The development of adverse cardiovascular events despite aspirin use has established an interest in a possible resistance to the drug. Several definitions have been set and various laboratory testing modalities are available. This has led to a wide range of prevalence reports in different clinical entities.
Khaled Mansour, Ali T. Taher, Khaled M. Musallam, Samir Alam   +3 more
openaire   +3 more sources

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Platelets, 2018
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis.
Andréas Perrier-Cornet, Jean-Christophe Ianotto, Fanny Mingant, Maëla Perrot, Eric Lippert, Hubert Galinat   +5 more
doaj   +1 more source

Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients

Journal of Translational Medicine, 2008
Background Our previous publication showed that 9% of patients with a history of myocardial infarction MI. could be labeled as aspirin resistant; all of these patients were aspirin resistant because of non-compliance.
Reeves Mathew, Barber Kimberly, Schwartz Dianne E, Schwartz Kenneth A, De Franco Anthony C   +4 more
doaj   +1 more source

Impact of aspirin on bleeding and blood product usage in off‐pump and on‐pump coronary artery bypass graft surgery

eJHaem, 2022
Major bleeding is linked to poorer outcomes following cardiac surgery. Current guidelines recommend continuation of aspirin prior to coronary artery by‐pass graft (CABG) but the effect of continuing aspirin in patients with prior indication for aspirin ...
Christopher Little, Zain Odho, Richard Szydlo, Tuan‐Chen Aw, Mike Laffan, Deepa R. J. Arachchillage   +5 more
doaj   +1 more source

Aile hekimliği polikliniğine başvuran hastalarda Aspirin kullanımının değerlendirilmesi

Cukurova Medical Journal, 2021
Amaç: Bu çalışmada Aspirin kullanımın amaçlarına yönelik bir değerlendirme yapmak ve hastalarda konuya ilişkin farkındalık oluşturmak amaçlanmıştır.
Mehmet Özen, Aysima Bulca Acar
doaj   +1 more source

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

New England Journal of Medicine, 2019
BACKGROUND Monotherapy with a P2Y12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI).
R. Mehran, U. Baber, Samin K. Sharma, D. Cohen, D. Angiolillo, C. Briguori, Jin Y Cha, T. Collier, G. Dangas, D. Dudek, V. Džavík, J. Escaned, R. Gil, P. Gurbel, C. Hamm, T. Henry, K. Huber, A. Kastrati, U. Kaul, R. Kornowski, M. Krucoff, V. Kunadian, S. Marx, S. Mehta, D. Moliterno, E. Ohman, K. Oldroyd, G. Sardella, S. Sartori, R. Shlofmitz, P. Steg, G. Weisz, B. Witzenbichler, Ya‐Ling Han, S. Pocock, C. Gibson   +35 more
semanticscholar   +1 more source

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine, 2020
BACKGROUND The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been ...
J. Brouwer, V. Nijenhuis, R. Delewi, R. Hermanides, W. Holvoet, C. Dubois, P. Frambach, B. de Bruyne, G. V. van Houwelingen, J. van der Heyden, P. Toušek, F. van der Kley, I. Buysschaert, C. Schotborgh, B. Ferdinande, P. van der Harst, J. Roosen, J. Peper, Frederick W F Thielen, L. Veenstra, D. R. Chan Pin Yin, M. Swaans, B. Rensing, A. W. van ’t Hof, L. Timmers, J. Kelder, P. Stella, J. Baan, J. T. ten Berg   +28 more
semanticscholar   +1 more source

Aspirin [PDF]

Journal of Thrombosis and Haemostasis, 2004
Smith JB, Mustard JF, Jilma B, FucksI, VIOLI, Francesco, PIGNATELLI, Pasquale, PULCINELLI, FABIO MARIA, de GaetanoG, Cerletti C, Rosenson SF, Wolff D, Green D, Boss AH, Kensey K.R.   +13 more
  +16 more sources

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

New England Journal of Medicine, 2018
BACKGROUND Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first ...
L. Bowman, M. Mafham, K. Wallendszus, W. Stevens, G. Buck, J. Barton, K. Murphy, Theingi Aung, R. Haynes, J. Cox, A. Murawska, A. Young, M. Lay, Fang Chen, E. Sammons, Emma Waters, A. Adler, J. Bodansky, A. Farmer, R. Mcpherson, A. Neil, D. Simpson, R. Peto, C. Baigent, R. Collins, S. Parish, J. Armitage   +26 more
semanticscholar   +1 more source

Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.

New England Journal of Medicine, 2020
BACKGROUND More information is needed about the long-term effects of low-dose aspirin (≤160 mg) on incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepatitis B or hepatitis C virus ...
Tracey G. Simon, Ann-Sofi Duberg, S. Aleman, R. Chung, A. Chan, J. Ludvigsson   +5 more
semanticscholar   +1 more source